Novartis might sell its non-strategic animal health and over-the-counter (OTC) businesses if it cannot turn them into businesses of global scale, Chief Executive Joe Jimenez told Reuters in an interview on Monday. He said Novartis had three global businesses -- pharma, eyecare and generics -- it was focusing on, but was looking at options for its three subscale businesses, vaccines and diagnostics, over-the-counter and animal health. “We looked very hard at the market growth rates and at Novartis’s capabilities. These are good businesses, but we have to find a way to give them global scale,” Jimenez said.
Help employers find you! Check out all the jobs and post your resume.
